07:00 , May 13, 2013 |  BC Week In Review  |  Company News

BioView, Kindstar Global deal

BioView and Kindstar partnered to conduct a Chinese pilot study of BioView's lung cancer detection kit. The 12-month deal includes an option for Kindstar to acquire a license to market the test in China. BioView...
08:00 , Dec 10, 2012 |  BC Week In Review  |  Company News

BioView, Abbott deal

The companies partnered to develop an automated scanning solution to detect rearrangements in genes encoding anaplastic lymphoma kinase (ALK) in patients with advanced non-small cell lung cancer (NSCLC). BioView will be responsible for expanding approval...
07:00 , Jul 23, 2012 |  BC Week In Review  |  Company News

BioView, ScreenCell sales and marketing update

BioView and ScreenCell entered into a non-exclusive agreement to offer BioView's cell imaging systems for use in imaging and characterizing circulating tumor cells (CTCs) isolated with ScreenCell's Cyto Kit. Both products are offered worldwide. Details...
08:00 , Dec 21, 2009 |  BC Week In Review  |  Company News

BioView Ltd., Clarient deal

The companies will co-develop BioView's non-invasive test for early detection of non-small cell lung cancer (NSCLC). The test uses DNA probes with BioView's Target Fluorescence in situ Hybridization (T-FISH) technology to screen for genetic biomarkers...